Probiotic-based immune enhancement therapy: Probiotic Clostridium butyricum MIYAIRI 588 (CBM588) increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene, 12/March/2019, 9.41 am